Back to Global NewsPublished: 23 Feb 2026Download AppJoin TelegramWhy Foghorn Therapeutics' New CFO Could Turbocharge Its Pipeline — Risks & Rewards#Foghorn Therapeutics#Biotech CFO#Investing#Gene Regulation#Clinical Stage BiotechDownload AppJoin CommunityShare Article